糖酵解
肝细胞癌
厌氧糖酵解
癌症研究
磷酸甘油酸激酶
细胞凋亡
酶
化学
体外
激酶
药理学
生物化学
生物
作者
Mingfeng Li,Aotong Zhang,Xin Qi,Rilei Yu,Jing Li
标识
DOI:10.1016/j.biopha.2022.114115
摘要
Phosphoglycerate kinase 1(PGK1) is an important enzyme in the metabolic glycolysis pathway. Nowadays, PGK1 is an appealing therapeutic target for multiple cancers. However, no effective inhibitor of PGK1 has been reported. In this study, we demonstrate that Ilicicolin H a 5-(4-hydroxyphenyl)-pyridone with a decalin ring system and a non-ATP-competitive inhibitor of PGK1, inhibits the proliferation and promotes apoptosis of Hepatocellular carcinoma (HCC). Many cancer cells display enhanced glycolysis which is critical for tumor development. Here we identified that Ilicicolin H can target PGK1 in vitro to inhibit the lactate production and glucose uptake of HCC cells. These findings suggest that the PGK1 inhibitor- Ilicicolin H is a promising anticancer agent and may provide a better therapeutic strategy for HCC treatment in the future.
科研通智能强力驱动
Strongly Powered by AbleSci AI